Full Length Research Paper
References
|
Ahouidi AD, Anderson M, Diédhiou CK, Dia A, Mbow M, Dia Y, Mbop M, Gaye AG, Manga AM, Cloherty G, Mboup S (2022). Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal. IJID Regions 2:96-98. |
|
|
Beaumont A, Durand C, Ledrans M, Schwoebel V, Noel H, Diulius D, Colombain L, Médus M, Gueudet P, Aumaître H (2021). Séroprévalence des anticorps anti-SARS-CoV-2 après la première vague épidémique au sein d'une population vulnérable. Infectious Diseases Now 51(5):S17-S18. |
|
|
Coelho LE, Luz PM, Pires DC, Jalil EM, Perazzo H,Torres TS, Cardoso SW, Peixoto EM, Nazer S, Massad E, Silveira MF, Barros FC, Vasconcelos ATR, Costa CAM, Amancio RT, Villela DAM, Pereira T, Goedert GT, Santos CVBD, Rodrigues NCP, Grinsztejn B, Veloso VG, Struchiner CJ (2022). Prévalence et prédicteurs de la sérologie anti-SRAS-CoV-2 dans une population très vulnérable de Rio de Janeiro: une enquête sérologique basée sur la population. The Lancet Regional Health - Americas 15:100338. |
|
|
Diouf I, Bousso A, Sonko I (2020). Gestion de la pandémie COVID-19 au Sénégal. Médecine de Catastrophe-Urgences Collectives 4(3):217-222. |
|
|
Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo G-Y, Du J, Zheng C-L, Zhu Q, Hu M, Li X-Y, Peng P, Shi H-Z (2020). Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. European Respiratory Journal 55(5):2000524. |
|
|
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, COVID-19 Lombardy ICU Network (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUS of the Lombardy region, Italy. JAMA 323(16):1574-1581. |
|
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Shao-yong Zhu SY, Zhong NS, for the China Medical Treatment Expert Group for Covid-19 (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 382(18):1708-1720. |
|
|
Guede CM, Koffi BAF, Guele GP (2021). Analyse spatiale et épidémiologie pour l'aide à la décision dans la lutte contre le Covid-19 en Côte d'Ivoire. European Scientific Journal 17:24-28. |
|
|
Hamid S, Mir MY, Rohela GK (2020). Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect 35:100679. |
|
|
Harboun M, Verdun S, Brénière V, Luquel L, Jourdan M, De Malherbe A (2022). Seroprevalence, risk factors and clinical presentation after the first wave of COVID-19 in nursing homes of the UNIVI group: The SEROCOVID study]. La Revue de Medecine Interne 43(2):75-81. |
|
|
Javanmardi F, Keshavarzi A, Akbari A, Emami A, Pirbonyeh N (2020). Prevalence of underlying diseases in died cases of COVID-19: A systematic review and meta-analysis. PloS one 15(10):e0241265. |
|
|
Kayem G, Lecarpentier E, Deruelle P, Bretelle F, Azria E, Blanc J, Bohec C, Bornes M, Ceccaldi PF, Chalet Y, Chauleur C (2020). A snapshot of the Covid-19 pandemic among pregnant women in France. Journal of Gynecology Obstetrics and Human Reproduction 49(7):101826. |
|
|
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S (2020). Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology 21(3):335-337. |
|
|
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine 27(2):1-4. |
|
|
Mbow M, Diallo I, Diouf M, Cisse? M, Gningue M, Mboup A, Leye N, Lo G, Dia YA, Padane A, Wade D (2022). Evaluation of the LumiraDx SARS-CoV-2 antigen assay for large-scale population testing in Senegal. International Journal of Clinical Virology 6(1):1-6. |
|
|
Mohan BS, Nambiar V (2020). COVID-19: An Insight into SARS-CoV-2 Pandemic Originated at Wuhan City in Hubei Province of China. Infectious Disease Epidemiology 6:146. |
|
|
Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, Shrestha BR, Arabi YM, Ng J, Gomersall CD, Nishimura M (2020). Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. The Lancet Respiratory Medicine 8(5):506-517. |
|
|
Riccardo F, Ajelli M, Andrianou XD, Bella A, Del Manso M, Fabiani M, Bellino S, Boros S, Urdiales AM, Marziano V, Rota MC (2020). Epidemiological characteristics of COVID-19 cases and estimates of the reproductive numbers 1 month into the epidemic, Italy, 28 January to 31 March 2020. Eurosurveillance 25(49):2000790. |
|
|
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R (2020). World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 76:71-76. |
|
|
Surveillances V (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China. China CDC weekly 2(8):113-122. |
|
|
Talla C, Loucoubar C, Roka JL, Barry MA, Ndiaye S, Diarra M, Thiam MS, Faye O, Dia M, Diop M, Ndiaye O (2022). Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020. IJID Regions 3:117-125. |
|
|
Wang A, Zhao W, Xu Z, Gu J (2020). Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Research And Clinical Practice 162:108118. |
|
|
Wang H, Zhang L (2020). Risk of COVID-19 for patients with cancer. The Lancet Oncology 21(4):e181. |
|
|
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J (2020). Factors associated with COVID-19-related death using Open SAFELY. Nature 584(7821):430-436. |
|
|
World Health Organization (2020). Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Geneva. |
|
|
Wu Z, McGoogan JM (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1939-42. |
|
|
Yang J, Zheng YA, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases. 94:91-95. |
|
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P (2020). A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine 382(8):727-733. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
